GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B5294 (+)-Igmesine hydrochlorideSummary: σ1 receptor ligand
- B5778 SA 4503 dihydrochlorideSummary: σ1 receptor agonist
- B1297 SiramesineSummary: Sigma (σ) receptor agonist
- B1179 S1RASummary: σ1R antagonist
- B1180 S1RA hydrochlorideSummary: σ1R antagonist
- B6469 DTGSummary: sigma receptor agonist
- B6330 BD 1008 dihydrobromideSummary: δ1-receptor antagonist,potent and selective
- B6364 PRE-084 hydrochloride1 CitationTarget: Sigma ReceptorsSummary: selective σ1 receptor agonist
- B6379 4-PPBP maleateSummary: σ ligand and NR1a/2B NMDA receptors antagonist
- B6433 4-IBPSummary: σ1 agonist